Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361620 · ClinicalTrials.gov registry record · NA
Genotypic and Phenotypic Correlates of Resistance to Aspirin
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT01361620 is a NA study that has completed, run by George Washington University. The registered enrollment target is 190 participants.
The verdict
NCT01361620, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The study seeks to identify genomic markers associated with aspirin resistance.
Interventions
- DRUG aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01361620
The ClinicalTrials.gov registry entry for NCT01361620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which aspirin is the first listed.
NCT01361620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01361620 about?
NCT01361620 is a clinical study titled "Genotypic and Phenotypic Correlates of Resistance to Aspirin". The study seeks to identify genomic markers associated with aspirin resistance.
What is the current status of trial NCT01361620?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2007-12. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01361620?
The interventions under investigation include: aspirin (DRUG).
Who is sponsoring clinical trial NCT01361620?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.